Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

roval decisions for new drug applications by health authorities is an uncertain and evolving process and health authorities retain significant discretion at all stages of the regulatory review and approval decision process; (iv) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of our technology platform to potential new drug candidates is therefore highly uncertain and unpredictable and one or more research and development programs could fail; (v) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (vi) the outcome of any existing or future intellectual property or other litigation related to our drug candidates and those of our collaboration partners.  Other important risks and uncertainties set forth in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2014. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.  Nektar Investor Inquiries: Jennifer Ruddock/Nektar Therapeutics

(415) 482-5585Susan Noonan/SA Noonan Communications, LLC

(212) 966-3650Nektar Media Inquiries:
Jodi Sievers/Nektar Therapeutics(415) 482-5593 NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(Unaudited)ASSETSJune 30, 2014Dece
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... DUBAI , UAE, May 6, 2015 ... information management solutions, has been named a "Cool Vendor" by ... Vendors in Emerging Markets 2015". Gartner defines a ... that are innovative, impactful and intriguing. The report ... leaders whose organizations operate in emerging markets should look at ...
(Date:5/6/2015)... , May 6, 2015 3D ... expanded its process for helping pharmaceutical companies communicate ... access. The newly expanded ... will go beyond helping companies develop and deliver ... to identify and engage critical stakeholders earlier in ...
(Date:5/6/2015)...   GenSpera, Inc. (OTCQB: GNSZ) announced today that ... phase application process in 17 countries and regions, including ... China , Brazil ... the resulting patent application will extend the exclusivity period for ... its lead drug candidate, mipsagargin, until 2033. This ...
Breaking Medicine Technology:UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 43D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... Reportlinker.com announces that a new market research ... Global Radiation Therapy Equipment Industry ... This report analyzes the worldwide markets ... by the following product segments: Linear Accelerator, ...
... Reportlinker.com announces that a new market research ... Top 1000 Pharmaceutical Manufacturers (Asian) ... The Asian Pharmaceutical Manufacturers Industry Report ... This report is an in-depth financial evaluation ...
Cached Medicine Technology:Global Radiation Therapy Equipment Industry 2Global Radiation Therapy Equipment Industry 3Global Radiation Therapy Equipment Industry 4Global Radiation Therapy Equipment Industry 5Global Radiation Therapy Equipment Industry 6Global Radiation Therapy Equipment Industry 7Global Radiation Therapy Equipment Industry 8Global Radiation Therapy Equipment Industry 9Global Radiation Therapy Equipment Industry 10Global Radiation Therapy Equipment Industry 11Global Radiation Therapy Equipment Industry 12Global Radiation Therapy Equipment Industry 13Global Radiation Therapy Equipment Industry 14Global Radiation Therapy Equipment Industry 15Global Radiation Therapy Equipment Industry 16Global Radiation Therapy Equipment Industry 17Global Radiation Therapy Equipment Industry 18Global Radiation Therapy Equipment Industry 19Global Radiation Therapy Equipment Industry 20Global Radiation Therapy Equipment Industry 21Global Radiation Therapy Equipment Industry 22Global Radiation Therapy Equipment Industry 23Global Radiation Therapy Equipment Industry 24Top 1000 Pharmaceutical Manufacturers (Asian) 2Top 1000 Pharmaceutical Manufacturers (Asian) 3Top 1000 Pharmaceutical Manufacturers (Asian) 4
(Date:5/6/2015)... May 06, 2015 Prime Pacific ... is excited to announce a new series of ... the industry’s carbon footprint while improving treatment efficacy ... Eco-Flex™, the world’s first waste hose ... game-changer for hydrotherapists,” claims the company’s president, Mr. ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part of its ... applications on the market for iOS, Android, and Windows. Joe Toohey, ... and shared with viewers how this application walks users through recipes. ... good navigator people had to know how to read a map? ... navigator. Well what if people could “GPS” their way through a ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 vcfo, a ... HR, IT and operational support to optimize business performance ... CFOs, Jack Lynch and Michael Scheaffer. Both Lynch and ... and leadership experience. , “We are delighted to ... Wood, vcfo CEO. “Leveraging their background in financial management ...
(Date:5/6/2015)... Healthcare jobs platform, JobMedic.com, has quickly ... The company connects hospitals, home-health, and other medical organizations ... industry. Likewise, job seekers are able to locate jobs ... unique traffic to the site is up more than ... posting brings targeted, interested candidates to the site through ...
(Date:5/6/2015)... The Alliance for Regenerative Medicine (ARM), ... advanced therapies community, today announced the release of ... look at sector trends and metrics from the ... is available online here and also ... here . , Using information provided by ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... seem largely visual the preening, the coy eye contact ... voice may be a means of demonstrating attraction, says Susan ... Pa., in a study, "Vocal and Physiological Changes in Response ... in the fall by the Journal of Nonverbal Behavior ...
... ... play weather, the National Recreation and Park Association (NRPA) is reminding Americans to take the ... To assist, NRPA has published The Dirty Dozen, a comprehensive brochure and playground-safety resource ... ...
... ... Patient Satisfaction Conference June 4th 2010. Expert speakers will discuss improving communications between caregivers, ... , ... 2010 -- Scan Am Company of Algonquin, Illinois, will be hosting a Patient Safety ...
... and when they were readmitted , THURSDAY, May 20 ... disease who decide to discharge themselves before their doctors ... and when they are readmitted. , The finding, set ... for Pharmacoeconomics and Outcomes Research meeting in Atlanta, comes ...
... Gastroesophageal reflux (GER), defined as passage of gastric contents ... in healthy infants, children and adults. When GER causes ... gastroesophageal reflux disease (GERD). During infancy, GER is common ... non-specific symptoms as irritability and cough. Association of non-specific ...
... a study published today in the journal Addiction , ... effective among people with severe mental illnesses as it is ... offering such treatments does not appear to cause deterioration in ... severe mental illnesses (SMI) such as schizophrenia have some of ...
Cached Medicine News:Health News:The sound of seduction 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 3Health News:Patient Safety and Satisfaction are Key Issues at Scan Am Company June Conference 2Health News:When Heart Patients Discharge Themselves, Hospital Bills Increase 2Health News:Disagreement on symptom-reflux association analysis parameters in infants 2Health News:Smoking cessation treatments work and are safe for people with severe mental illness 2
Non-sterile oncoseed seeds consists of a welded titanium capsule containing....
... High Refractive Index glass provides total ... contact with the mirrors. Total internal ... loss by a mirror coating resulting ... resolution image of the anterior chamber ...
... lens available for gonioscopy ... 62 mirror. Tilted anterior ... laser beam astigmatism. Unsurpassed ... on most patients without ...
Lacrimal cannula blunt tip with 0.3 mm side port, straight....
Medicine Products: